• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LMNB2 是肝细胞癌的预后生物标志物,并与免疫浸润相关。

LMNB2 is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.

机构信息

Department of Emergency Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Department of Emergency Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

出版信息

IUBMB Life. 2020 Dec;72(12):2672-2685. doi: 10.1002/iub.2408. Epub 2020 Nov 19.

DOI:10.1002/iub.2408
PMID:33211382
Abstract

BACKGROUND

Previous studies have suggested Lamin B2 (LMNB2) as an oncogene in lung cancer. However, the role of LMNB2 in hepatocellular carcinoma (HCC) remains unclear.

METHOD

The expression of LMNB2 was compared between HCC samples and non-tumor samples in multiple datasets. In addition, the prognostic value of LMNB2 in HCC was also investigated. Furthermore, the cBioPortal was utilized to analyze the genomic alternation of LMNB2 in HCC. Besides, co-expression genes and functional enrichment analysis were evaluated using LinkedOmics to determine the function of LMNB2. Finally, the correlation between LMNB2 and immune infiltration was assessed using Tumor Immune Estimation Resource (TIMER).

RESULTS

Elevated LMNB2 expression level was identified in HCC patients in multiple datasets. Moreover, increased levels of LMNB2 were associated with poor overall survival (OS) and disease-free survival (DFS). The functional enrichment analysis revealed that LMNB2 plays an essential role via the cell cycle pathway, spliceosome, hippo-signaling pathway, and metabolic pathways. Besides, copy number variation (CNV) and methylation were significantly associated with LMNB2 expression. Additionally, increased levels of LMNB2 were significantly associated with B cells, CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and dendritic cells.

CONCLUSION

LMNB2 is a potential HCC prognostic and diagnostic biomarker.

摘要

背景

先前的研究表明 lamin B2(LMNB2)是肺癌的癌基因。然而,LMNB2 在肝细胞癌(HCC)中的作用尚不清楚。

方法

在多个数据集之间比较了 HCC 样本和非肿瘤样本中 LMNB2 的表达。此外,还研究了 LMNB2 在 HCC 中的预后价值。此外,利用 cBioPortal 分析了 HCC 中 LMNB2 的基因组改变。此外,使用 LinkedOmics 评估了共表达基因和功能富集分析,以确定 LMNB2 的功能。最后,使用 Tumor Immune Estimation Resource(TIMER)评估了 LMNB2 与免疫浸润的相关性。

结果

在多个数据集的 HCC 患者中,鉴定出 LMNB2 表达水平升高。此外,LMNB2 水平升高与总生存期(OS)和无病生存期(DFS)不良相关。功能富集分析表明,LMNB2 通过细胞周期途径、剪接体、 Hippo 信号通路和代谢途径发挥重要作用。此外,拷贝数变异(CNV)和甲基化与 LMNB2 表达显著相关。此外,LMNB2 水平升高与 B 细胞、CD8+T 细胞、CD4+T 细胞、巨噬细胞、中性粒细胞和树突状细胞显著相关。

结论

LMNB2 是 HCC 潜在的预后和诊断生物标志物。

相似文献

1
LMNB2 is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.LMNB2 是肝细胞癌的预后生物标志物,并与免疫浸润相关。
IUBMB Life. 2020 Dec;72(12):2672-2685. doi: 10.1002/iub.2408. Epub 2020 Nov 19.
2
Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.肝细胞癌中 COMMD 蛋白家族的表达、预后价值和免疫浸润活性的转录分析。
BMC Cancer. 2021 Sep 7;21(1):1001. doi: 10.1186/s12885-021-08699-3.
3
Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.羟甾体 17-β 脱氢酶 6 是肝癌的预后生物标志物,并与免疫浸润相关。
Dig Dis Sci. 2022 Jan;67(1):146-158. doi: 10.1007/s10620-021-06832-7. Epub 2021 Jan 26.
4
Prognostic potential of PRPF3 in hepatocellular carcinoma.PRPF3 在肝细胞癌中的预后潜力。
Aging (Albany NY). 2020 Jan 11;12(1):912-930. doi: 10.18632/aging.102665.
5
EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma.EOGT 与免疫浸润相关:肝细胞癌的候选预后生物标志物。
Front Immunol. 2022 Jan 5;12:780509. doi: 10.3389/fimmu.2021.780509. eCollection 2021.
6
PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma.PPM1D 是肝癌潜在的预后生物标志物,与免疫细胞浸润相关。
Aging (Albany NY). 2021 Sep 1;13(17):21294-21308. doi: 10.18632/aging.203459.
7
CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.CDKN2A 是肝细胞癌的预后生物标志物,并与免疫浸润相关。
Biosci Rep. 2021 Oct 29;41(10). doi: 10.1042/BSR20211103.
8
High mRNA Expression of and Its Significance in Prognosis of Hepatocellular Carcinoma Patients.[某种物质]的高mRNA表达及其在肝细胞癌患者预后中的意义
Dis Markers. 2021 Aug 17;2021:9971799. doi: 10.1155/2021/9971799. eCollection 2021.
9
Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.环状鸟苷酸-腺苷酸合成酶-干扰素基因刺激蛋白信号通路在肝细胞癌中的预后生物标志物鉴定及其与免疫浸润的相关性。
Biosci Rep. 2020 Oct 30;40(10). doi: 10.1042/BSR20202603.
10
Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.锌指蛋白 2 与肝癌免疫浸润的相关性:一个预后生物标志物。
Biosci Rep. 2021 Jan 29;41(1). doi: 10.1042/BSR20203115.

引用本文的文献

1
Lamins regulate cancer cell plasticity and chemosensitivity.核纤层蛋白调节癌细胞的可塑性和化学敏感性。
Front Oncol. 2025 Jul 10;15:1599175. doi: 10.3389/fonc.2025.1599175. eCollection 2025.
2
LMNB2-mediated high PD-L1 transcription triggers the immune escape of hepatocellular carcinoma.LMNB2介导的高PD-L1转录触发肝细胞癌的免疫逃逸。
Cell Death Discov. 2025 Jun 7;11(1):269. doi: 10.1038/s41420-025-02540-7.
3
Mitochondrial permeability transition drives the expression, identification and validation of necrosis-related genes in prognostic risk models of hepatocellular carcinoma.
线粒体通透性转换驱动肝细胞癌预后风险模型中坏死相关基因的表达、鉴定及验证。
Transl Cancer Res. 2025 Feb 28;14(2):1037-1052. doi: 10.21037/tcr-24-1442. Epub 2025 Feb 26.
4
Comprehensive analysis of LMNB2 in pan-cancer and identification of its biological role in sarcoma.泛癌中LMNB2的综合分析及其在肉瘤中的生物学作用鉴定。
Aging (Albany NY). 2024 Jul 8;17(1):203-216. doi: 10.18632/aging.205962.
5
Pan-cancer TCGA analysis reveals the potential involvement of B-type lamins in dysregulating chromosome segregation in human cancer.泛癌TCGA分析揭示了B型核纤层蛋白在人类癌症中失调染色体分离过程中的潜在作用。
Mamm Genome. 2025 Mar;36(1):230-249. doi: 10.1007/s00335-024-10086-9. Epub 2024 Nov 27.
6
An In-Depth Approach to the Associations between MicroRNAs and Viral Load in Patients with Chronic Hepatitis B-A Systematic Review and Meta-Analysis.深入探讨慢性乙型肝炎患者中 microRNAs 与病毒载量之间的关联:系统评价和荟萃分析。
Int J Mol Sci. 2024 Aug 1;25(15):8410. doi: 10.3390/ijms25158410.
7
A Lamin Family-Based Signature Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.基于 lamin 家族的signature 可预测肝细胞癌的预后和免疫治疗反应。
J Immunol Res. 2022 Nov 10;2022:4983532. doi: 10.1155/2022/4983532. eCollection 2022.
8
Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway.肝细胞癌和肝内胆管癌的预后及治疗靶点研究进展:河马信号通路
Front Oncol. 2022 Aug 12;12:937957. doi: 10.3389/fonc.2022.937957. eCollection 2022.
9
Lamin B2 contributes to the proliferation of bladder cancer cells via activating the expression of cell division cycle‑associated protein 3.核纤层蛋白B2通过激活细胞分裂周期相关蛋白3的表达促进膀胱癌细胞的增殖。
Int J Mol Med. 2022 Sep;50(3). doi: 10.3892/ijmm.2022.5168. Epub 2022 Jul 1.
10
Comprehensive analysis of expression and prognosis for LMNB family genes in human sarcoma.全面分析人肉瘤中 LMNB 家族基因的表达和预后。
Medicine (Baltimore). 2022 Mar 18;101(11). doi: 10.1097/MD.0000000000028933.